Psychosocial issues in hepatitis C: A qualitative analysis

Psychosomatics

Volumn 49, Issue 6, 2008, Pages 494-501

  Janke, E Amy ^a   McGraw, Sarah ^b   Garcia Tsao, Guadalupe ^b   Fraenkel, Liana ^b  

^a HINES VA HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HEPATITIS C; HUMAN; MALE; QUALITATIVE ANALYSIS; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT;

EID: 61849183584     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.49.6.494     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention: Hepatitis Surveillance Report #60. Atlanta, GA, U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, 2005
2. Alter MJ, Kruszon-Moran D, Nainan OV, et al: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-562
3. Wong JB, McQuillan GM, McHutchison JG, et al: Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90:1562-159
4. Pessoa MG, Wright TL: Hepatitis C infection in transplantation. Clinical Liver Disease 1997; 1:663-690
5. Centers for Disease Control and Prevention: Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease. MMWR 1998; 47(RR19); pp 1-39
6. 2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C: Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:1485-1492
7. 2b therapy. J Clin Psychiatry 2003; 64:708-714
8. Bonkovsky HL, Woolley JM: Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy: The Consensus Interferon Study Group. Hepatology 1999; 29:264-270
9. Foster GR: Hepatitis C virus infection: quality of life and side effects of treatment. J Hepatol 1999; 31(suppl 1):250-254
10. Fontana RJ, Hussain KB, Schwartz SM, et al: Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol 2002; 36:401-407
11. Kraus MR, Schafer A, Csef H, et al: Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics 2000; 41:377-384
12. Zdilar D, Franco-Bronson K, Buchler N, et al: Hepatitis C, interferon-alfa, and depression. Hepatology 2000; 31:1207-1211
13. Zickmund S, Ho EY, Masuda M, et al: "They treated me like a leper:" stigmatization and the quality of life of patients with hepatitis C. J Gen Intern Med 2003; 18:835-844
14. Zickmund S, Hillis SL, Barnett MJ, et al: Hepatitis C virus-infected patients report communication problems with physicians. Hepatology 2004; 39:999-1007
15. Soto TA, Bell J, Pillen MB: HIV/AIDS Treatment Adherence, Health Outcomes, and Cost-Study Group: Literature on integrated HIV care: a review. AIDS Care 2004; 16(suppl 1):S43-S55
16. Fireman M, Indest DW, Blackwell Scientific A, et al: Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a co-management model of care. Clin Infect Dis 2005; 40(suppl5):S286-S291
17. Loftis JM, Hauser P: Safety of the treatment of interferon-alpha-induced depression. Psychosomatics 2003; 44:524-526
18. Fraenkel L, McGraw S, Wongcharatrawee S, et al: What do patients consider when making decisions about treatment for hepatitis C? Am J Med 2005; 118:1387-1391
19. Fraenkel L, McGraw S, Wongcharatrawee S, et al: Patients' experiences related to anti-viral treatment for hepatitis C. Patient Educ Couns 2006; 62:148-155
20. Glaser B, Strauss A: The Discovery of Grounded Theory: Strategies for Qualitative Research. New York, Aldine Company; 1967
21. Miles M, Huberman AM: Qualitative Data Analysis: An Expanded Sourcebook. Thousand Oaks, CA, Sage, 1994
22. 2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339:1485-1492
23. Booth JC, O'Grady J, Neuberger J: Clinical guidelines on the management of hepatitis C. Gut 2001; 49(suppl 1):I1-I21
24. Yovtcheva SP, Rifai MA, Moles JK, et al: Psychiatric comorbidity among hepatitis C-positive patients. Psychosomatics 2001; 42:411-415
25. Constant A, Castera L, Dantzer R, et al: Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms. J Clin Psychiatry 2005; 66:1050-1057
26. Kraus MR, Schafer A, Csef H, et al: Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition. Dig Dis Sci 2001; 46:2060-2065
27. NIH Consensus Statement on Management of Hepatitis C, 2002. NIH Consens State Sci Statements 2002; 19(3):1-46
28. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000
29. Akiskal HS, Maser JD, Zeller PJ, et al: Switching from "unipolar" to bipolar II: an 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 1995; 52:114-123
30. Benazzi F, Akiskal H: Irritable-hostile depression: further validation as a bipolar depressive mixed state. J Affect Disord 2005; 84(2-3):197-207
31. Angelino AF, Treisman GJ: Evidence-informed assessment and treatment of depression in HCV and interferon-treated patients. Int Rev Psychiatry 2005; 17:471-476
32. Akiska HS, Pinto O: The evolving bipolar spectrum: prototypes I, II, III, and IV: in Bipolarity: Beyond Classic Mania (edited by Akiskal HS). Psychiatr Clin North Am 1999; 22:517-534
33. Benazzi F, Koukopoulos A, Akiskal HS: Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression). Eur Psychiatry 2004; 19:85-90